SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-08 |
| Reported value | $177,219,142 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Parabilis Medicines, Inc. | PBLS | Common Stock | $114,041,648 | 4,166,666 |
| Intellia Therapeutics, Inc. | NTLA | Common Stock | $62,654,675 | 3,702,995 |
| Adicet Bio, Inc. | ACET | Common Stock | $522,819 | 60,511 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.